Andreas Maetzel, Senior Vice President Medical at KalVista Pharmaceuticals, Inc. (KALV), sold 5,000 shares at $30.00 ($150K) on 2019-04-05, disclosed to the SEC on 2019-04-09.
Open-market sale of $150k KALV by Senior Vice President Medical. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.